A Phase 3, Pivotal, Open-Label, Multicenter Study to assess the efficacy and safety of BIVV009 in patients with Primary Cold Agglutinin Disease who have a recent history of blood transfusion

Project: Research

StatusActive
Effective start/end date18/08/188/08/21